Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5171551
Max Phase: Preclinical
Molecular Formula: C38H65N13O8S2
Molecular Weight: 896.15
Associated Items:
ID: ALA5171551
Max Phase: Preclinical
Molecular Formula: C38H65N13O8S2
Molecular Weight: 896.15
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H](CCSSCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C38H65N13O8S2/c1-22(2)20-29(36(58)59)50-32(54)26(13-18-60-61-19-14-39)47-33(55)28(21-23-9-11-24(52)12-10-23)49-34(56)30-8-5-17-51(30)35(57)27(7-4-16-46-38(43)44)48-31(53)25(40)6-3-15-45-37(41)42/h9-12,22,25-30,52H,3-8,13-21,39-40H2,1-2H3,(H,47,55)(H,48,53)(H,49,56)(H,50,54)(H,58,59)(H4,41,42,45)(H4,43,44,46)/t25-,26+,27-,28-,29-,30-/m0/s1
Standard InChI Key: GJIFCEKRNNRBMK-CEIPDFQMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 896.15 | Molecular Weight (Monoisotopic): 895.4520 | AlogP: -1.42 | #Rotatable Bonds: 28 |
Polar Surface Area: 370.08 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 18 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.77 | CX Basic pKa: 11.68 | CX LogP: -6.25 | CX LogD: -9.11 |
Aromatic Rings: 1 | Heavy Atoms: 61 | QED Weighted: 0.02 | Np Likeness Score: 0.12 |
1. Einsiedel J, Schmidt MF, Hübner H, Gmeiner P.. (2022) Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors., 61 [PMID:35334449] [10.1016/j.bmc.2022.116720] |
Source(1):